Skip to main content

Revenue path, not valuation theater

The realistic path to a $2M Krasyn is 20–30 group practices, not hundreds of tiny trials.

A $2M company needs evidence a buyer can underwrite: real monthly recurring revenue, activation, retention, and a repeatable segment. This page is the operating path for practices that might fit that motion. It is not a clinical outcome promise and it does not ask for patient data.

No patient identifiers, charts, messages, recordings, or clinical details belong in the request. Use role names and workflow labels only.

Target MRR

$30k–$45k

This is the objective band that can support a $2M SaaS valuation at roughly 4–6× ARR.

Customer shape

20–30

Small outpatient groups are the fastest realistic path because each account can represent more than a solo-provider subscription.

Proof standard

Activated

Signup alone is not enough. Krasyn has to show the practice reached a first workflow outcome and kept using it.

Milestones a buyer can verify

Proof wedge

3 group practices in the same segment

Shows that the workflow is not a one-off founder sale.

Repeatable motion

10 activated group practices

Lets a buyer underwrite onboarding, activation, and retention risk.

$2M company path

20–30 group practices paying about $1.5k–$2k MRR each

Gets Krasyn near the $30k–$45k MRR band that can support a $2M SaaS valuation.

Who this is for

  • 4–15 clinicians or providers
  • Outpatient practice only
  • A named workflow owner for billing, documentation, follow-up, or intake
  • Willing to run one workflow proof before a full migration decision
  • No patient data in the first fit-review request

What we measure

  • MRR and annual commitment on trusted lifecycle events
  • Activation evidence for the first workflow, not just account creation
  • Segment and provider-count attribution
  • Capacity and fit-review demand counted separately from generic failures
  • A clear no-go boundary when the practice needs capabilities Krasyn should not promise yet

If your practice fits, start with one workflow.

The first review is about fit and workflow shape, not a full migration. Tell us the practice size, the bottleneck, and the system you use today. No patient data.

Request the fit review